Kesimpta 20 MG/0.4 ML pen 0.4ML
Ended Awarded
- Contract number
- SPE2DB25FS5FL
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $22,265
Award facts
- Contract value 100% obligated
- $22,264.84 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $22,264.84 to AmerisourceBergen Drug Corp for the supply of Kesimpta 20 mg/0.4 ml pen injectors. This non-competitive, firm fixed price delivery order was issued on June 2, 2025, with an ultimate completion date of June 3, 2025, and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. Kesimpta is a disease-modifying therapy used in the treatment of multiple sclerosis, representing a specialized pharmaceutical product within the Defense Health Agency's medical supply requirements.
This delivery order is issued under AmerisourceBergen Drug Corp's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999.99 billion prime vendor agreement running through December 2026 that establishes the company as a primary pharmaceutical distributor for military healthcare systems worldwide. As a child contract under this comprehensive global pharmaceutical support vehicle, the Kesimpta delivery order demonstrates the vendor's ongoing role in supplying specialty medications and brand-name drugs to support federal military healthcare programs. AmerisourceBergen Drug Corp, one of the nation's largest pharmaceutical distributors, regularly fulfills federal medical procurement needs through competitive award mechanisms, with this order reflecting the company's consistent capability to deliver critical pharmaceutical products to Defense Department healthcare operations.
Quick answers
Who was awarded contract SPE2DB25FS5FL?
SPE2DB25FS5FL was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on June 2, 2025.
How much is contract SPE2DB25FS5FL worth?
The government has obligated $22,265 on SPE2DB25FS5FL.
Is contract SPE2DB25FS5FL an order under another contract?
Yes. SPE2DB25FS5FL is a delivery order under SPE2DB22D2214, an indefinite delivery contract.
Was contract SPE2DB25FS5FL competed?
The extent of competition for SPE2DB25FS5FL was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award